To evaluate the rate of progression towards specific autoimmune diseases (SADs) of a prospective, multi-centre cohort of patients classifiable as interstitial pneumonia with autoimmune features (IPAF).
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study / Sambataro, G., Sambataro, D., Spicuzza, L., Meloni, F., Lorini, G., Malatino, L., Colaci, M., Sebastiani, G., Iuliano, A., Canofari, C., Luppi, F., Franco, G., Zanini, U., Manfredi, A., Gozzi, F., Sebastiani, M., Palmucci, S., Cavagna, L., Vancheri, C.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 41:5(2023), pp. 1140-1148. [10.55563/clinexprheumatol/lycdca]
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study
Colaci, Michele;Luppi, Fabrizio;Manfredi, Andreina;Gozzi, Filippo;Sebastiani, Marco;
2023
Abstract
To evaluate the rate of progression towards specific autoimmune diseases (SADs) of a prospective, multi-centre cohort of patients classifiable as interstitial pneumonia with autoimmune features (IPAF).
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
